Characterization of binding of human lactoferrin to pneumococcal surface protein A

Infection and Immunity

Volumn 69, Issue 5, 2001, Pages 3372-3381

  Hakansson A ^a   Roche, H ^a   Mirza, S ^a   McDaniel, L S ^a   Brooks Walter, A ^a   Briles, D E ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; LACTOFERRIN; MEMBRANE PROTEIN; PNEUMOCOCCUS SURFACE PROTEIN A; PNEUMOCOCCUS SURFACE PROTEIN C; TRANSFERRIN; UNCLASSIFIED DRUG;

ALPHA HELIX; AMINO ACID SEQUENCE; ARTICLE; BACTERIUM ADHERENCE; BINDING SITE; CONTROLLED STUDY; ESCHERICHIA COLI; HOST RESISTANCE; IMMUNOMODULATION; MORAXELLA CATARRHALIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; BACTERIAL PROTEINS; BINDING SITES; CATTLE; COMPLEMENT ACTIVATION; HUMANS; LACTOFERRIN; SPECIES SPECIFICITY; STREPTOCOCCUS PNEUMONIAE;

EID: 0035061043     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.5.3372-3381.2001     Document Type: Article

References (60)

1. Identification of a disaccharide unit of a glycoconjugate receptor for pneumocci attaching to human pharyngeal epithelial cells
2. Adhesion of Streptococcus pneumoniae to human pharyngeal epithelial cells in vitro: Differences in adhesive capacity among strains isolated from subjects with otitis media, septicemia or meningitis or from healthy donors
3. A prospective cohort study on breast-feeding and otitis media in Swedish infants
4. Nasopharyngeal colonization during the first year of life
5. A bactericidal effect for human lactoferrin
6. Studies on the chemical nature of the substance inducing transformation of pneumococcal types. Induction of transformation by a deoxyribonuceic acid fraction isolated from pneumococcus type III
7. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin
8. Lactoferrin turnover in man
9. Characterization of lbpA, the structural gene for a lactoferrin receptor in Neisseria gonorrhoeae
10. Characterization of Moraxella (Branhamella) catarrhalis lbpB, lbpA, and lactoferrin receptor orf3 isogenic mutants
11. Biochemical analysis of lactoferrin receptors in the Neisseriaceae: Identification of a second bacterial lactoferrin receptor protein
12. Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae
13. Mouse IgG3 antibodies are highly protective against infection with Streptococcus pneumoniae
14. Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA
15. PspA and PspC: Their potential for use as pneumococcal vaccines
16. PspA, a protection-eliciting pneumococcal protein: Immunogenicity of isolated native PspA in mice
17. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae
18. 3H-labeled teichoic acid
19. The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia
20. Lactoferrin acts on I-a and I-e/c antigen+ subpopulations of mouse peritoneal macrophages in the absence of T lymphocytes and other cell types to inhibit production of granulocytemacrophage colony stimulatory factors in vitro
21. Identification of lactoferrin as the granulocyte-derived inhibitor of colony-stimulating activity production
22. The role of lactoferrin in the bactericidal function of polymorphonuclear leucocytes
23. Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae
24. Pathogenic neisseriae can use hemoglobin, transferrin, and lactoferrin independently of the tonB locus
25. Cloning and expression of the Moraxella catarrhalis lactoferrin receptor genes
26. Epidemiologic studies of Streptococcus pneumoniae in infants: Acquisition, carriage, and infection during the first 24 months of life
27. Bacterial transferrin and lactoferrin receptors
28. Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae
29. SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component
30. An unmodified heptadecapeptide pheromone induces competence for genetic transformation in Streptococcus pneumoniae
31. Diversity of PspA: Mosaic genes and evidence for past recombination in Streptococcus pneumoniae
32. Production and characterization of the functional fragment of pneumococcal surface protein A
33. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin
34. Modulation of classical C3 convertase of complement by tear lactoferrin
35. An iron-binding protein common to many external secretions
36. Lactoferrin, an iron-binding protein in neutrophilic leukocytes
37. Lactoferrin or a fragment thereof inhibits the endotoxin-induced interleukin-6 response in human monocytic cells
38. Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260
39. PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type
40. Human lactotransferrin: Amino acid sequence and structural comparisons with other transferrins
41. Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules
42. Molecular characterization of LbpB, the second lactoferrin-binding protein of Neisseria meningitidis
43. Activation of the classical pathway of complement by binding of bovine lactoferrin to unencapsulated Streptococcus agalactiae
44. Cross-reactive protection eliciting epitopes of pneumococcal surface protein A
45. Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae
46. Characterization of the human transferrin and lactoferrin receptors in Haemophilus influenzae
47. Identification and characterization of the transferrin receptor from Neisseria meningitidis
48. Destruction of low efficiency markers is a slow process occurring at a heteroduplex stage of transformation
49. C3 as substrate for adhesion of Streptococcus pneumoniae
50. Hemin utilization is related to virulence of Streptococcus pneumoniae
51. Novel streptococcal-integration shuttle vectors for gene cloning and inactivation
52. Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice
53. Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae
54. Inhibition of hemolytic complement activity by lactoferrin in tears
55. Nasopharyngeal colonization in Costa Rican children during the first year of life
56. Lactoferrin: A multifunctional glycoprotein
57. Does breastfeeding affect the infant's immune responsiveness?
58. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment
59. Truncated forms of PspA that are secreted from Streptococcus pneumoniae and their use in functional studies and cloning of the pspA gene
60. Novel surface attachment mechanism of the Streptococcus pneumoniae protein PspA